Navigation Links
PharmAthene Reports First Quarter 2009 Financial and Operational Results
Date:5/15/2009

idates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.

                                -- Tables Follow --

                                 PHARMATHENE, INC.

                            CONSOLIDATED BALANCE SHEETS

                                               March 31,     December 31,
                                                 2009            2008
                                             (unaudited)

                         ASSETS
    Current assets:
      Cash and cash equivalents               $17,245,420     $19,752,404
      Restricted cash                           9,000,000      12,000,000
      Short-term investments                    6,773,594       3,190,912
      Accounts receivable                       9,961,596       8,890,077
      Other receivables                         1,089,857       1,391,512
      Prepaid expenses and other current assets   960,939         917,125
    Total current assets                       45,031,406      46,142,030

    Long-term restricted cash                           -       1,250,000
    Property and equipment, net                 5,211,214       5,313,219
    Patents, net                                  875,098         925,489
    Other long-term assets                        223,026         220,531
    Deferred costs                                 34,643          37,092
    Goodwill                                    2
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... First articles published now ... Elsevier , a world-leading provider of scientific, technical ... announce the launch of a new journal: ... The launch of Extreme Mechanics Letters is ... of applied sciences such as micro and nanotechnologies, biotechnologies, ...
(Date:11/26/2014)... 2014 Deep Research Report on Global ... research report on the Ammonium Bifluoride market, it ... application, and industry chain structure as well as ... analysis, including China’s domestic market as well as ... Japan etc. regions) industry analysis covering macroeconomic environment ...
(Date:11/26/2014)... Nov. 26, 2014 The Alliance ... a survey of European physicians at the "1 ... and Biological Therapies" at the Spanish Ministry of ... by EuropaBio and the Spanish Bioindustry Association (ASEBIO), ... physicians from Spanish oncology and rheumatology societies, representatives ...
(Date:11/26/2014)... 2014 SonaCare Medical, a leading ... devices, recently participated in the American Urology Association’s ... .” Key opinion leaders in urology presented on ... small renal masses while attendees had the opportunity ... in hands-on labs. Attendees at the Los Angeles, ...
Breaking Biology Technology:Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3ASBM Presents European Physicians Survey at Spanish Ministry of Health 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3
... Cylex Incorporated® today announced that the Centers for ... the reimbursement for ImmuKnow® , the immune cell ... immune response in populations undergoing immunosuppressive therapy for ... a time when the overall CMS clinical fee ...
... Dec. 14, 2010 Tolerx, Inc., a biopharmaceutical company ... by modulating T cell activity, today announced that it ... the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, ... by enabling T cells to more effectively attack cancer ...
... dioxide underground in an effort to combat global warming may ... triggering small- to moderate-sized earthquakes, according to Stanford geophysicist Mark ... big enough to hurt people or property, they could still ... "It is not the shaking an earthquake causes at ...
Cached Biology Technology:Reimbursement Rate Nearly Tripled for Cylex's ImmuKnow® Assay 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 3Earthshaking possibilities may limit underground storage of carbon dioxide 2Earthshaking possibilities may limit underground storage of carbon dioxide 3Earthshaking possibilities may limit underground storage of carbon dioxide 4
(Date:11/7/2014)... 2014 Leading Biometric companies aim to ... revolutionizing online transactions.  Companies in focus today are: NXT-ID, Inc. ... BABA ), Google Inc. (NASDAQ: GOOG ), ... EBAY ) and MasterCard Inc. (NYSE: MA) ... a biometric authentication company focused on the growing mobile commerce ...
(Date:11/6/2014)... asset for a predator. Except when that predator runs so ... relative to its size, is the fastest creature on Earth. ... per second (at about five miles per hour). The fastest ... sprinting gold from the tiger beetle, a person would have ... beetle has a problem. At peak speeds, everything becomes a ...
(Date:11/5/2014)... – Kelly Redmond has dedicated his career to ... to a general audience. , As deputy director ... Center at Nevada,s Desert Research Institute, Redmond has ... management, application and dissemination of climate data to ... Fall Meeting in San Francisco on December 15-19, ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6The tiger beetle: Too fast to see 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... can drop pounds quickly in the early phases of a ... keep the weight off in the long term. For ... weight loss even more challenging. A new study finds ... weight loss in the short term are not effective or ...
... is proud to welcome five new titles and their ... Marine Resource Economics , published by the Marine Resource ... Cryptogamie, Mycologie , three journals from France,s Association des ... , a new, open access, online only publication from ...
... beneficial bacteria, plants can slam the door when disease pathogens ... scientific team under the leadership of Harsh Bais, assistant professor ... and Natural Resources, found that when pathogens attempt to invade ... a surprising ally comes to the rescue. Soil bacteria at ...
Cached Biology News:Is long-term weight loss possible after menopause? 2Is long-term weight loss possible after menopause? 3BioOne announces 2013 Collections 2Behind closed doors: Researchers show how probiotics boost plant immunity 2Behind closed doors: Researchers show how probiotics boost plant immunity 3
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
...
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Biology Products: